Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages

Experimental Cell Research

Volumn 316, Issue 19, 2010, Pages 3140-3149

  Syed, Mansoor Ali ^a   Joo, M ^b   Abbas, Zulfiqar ^a   Rodger, D ^a   Christman, J W ^a   Mehta, D ^a   Sadikot, R T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Pusan National University   (South Korea)

Author keywords

Inflammation; LPS; Macrophage; Prostaglandin; TREM 1

Indexed keywords

CYCLOPENTANONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN J2; TRANSCRIPTION FACTOR NRF2; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; NFE2L2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA; TREM1 PROTEIN, MOUSE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; INHIBITION KINETICS; MACROPHAGE; MEDIATOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CELL NUCLEUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALIA; PSEUDOMONAS AERUGINOSA;

ANIMALS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; NF-E2-RELATED FACTOR 2; PPAR GAMMA; PROSTAGLANDIN D2; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 77958088641     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.009     Document Type: Article

References (40)

1. Ford J.W., McVicar D.W. TREM and TREM like receptors in inflammation and disease. Curr. Opin. Immunol. 2009, 21:38-46.
2. Sharif O., Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008, 213:701-713.
3. Colonna M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003, 3:1-9.
4. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J. Infect. Dis. 2003, 183:S397-S401.
5. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000, 164:4991-4995.
6. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
7. Klesney-Tait J., Colonna M. Uncovering the TREM-1-TLR connection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L1374-L1376.
8. Ornatowska M., Azim A.C., Wang X., Christman J.W., Xiao L., Joo M., Sadikot R.T. Functional genomics of silencing TREM-1on TLR4 signaling in macrophages. Am. J. Lung Physiol. 2007, 293:L1377-L1384.
9. Zeng H., Ornatowska M., Joo M., Sadikot R.T. TREM-1 expression in macrophage is regulated at transcriptional level by NF-κB and PU.1. Eur. J. Immunol. 2007, 7:2300-2308.
10. Gibot S., Kolopp-Sarda M.N., Bene M.C., Bollaert P.E., Lozniewski A., Mory F. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 2004, 200:1419-1426.
11. Gibot S., le Renard P.E., Béné M.C., Faure G.C., Bollaert P.E., Levy B. Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis. Crit. Care Med. 2005, 33:1787-1793.
12. Gibot S., Buonsanti C., Massin F., Romano M., Kolopp-Sarda M.N., Benigni F., Faure G.C., Bene M.C., Panina-Bordignon P., Passini N., Levy B. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect. Immun. 2006, 74:2823-2830.
13. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
14. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56:387-437.
15. Hirata M., Kakizuka A., Aizawa M., Ushikubi F., Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. USA 1994, 91:11192-11196.
16. Boie Y., Sawyer N., Slipetz D.M., Metters K.M., Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 1995, 270:18910-18916.
17. Hata A.N., Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 2004, 103:147-166.
18. Bos C.L., Richel D.J., Ritsema T., Peppelenbosch M.P., Versteeg H.H. Prostanoids and prostanoid receptors in signal transduction. Int. J. Biochem. Cell Biol. 2004, 36:1187-1205.
19. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid Receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 2001, 41:661-690.
20. 2: the anti-inflammatory prostaglandins?. Clin. Immunol. 2005, 114:100-109.
21. Scher J.U., Pillinger M.H. The anti-inflammatory effects of prostaglandins. J. Investig. Med. 2009, 57:703-708.
22. Sadikot R.T., Zeng H., Joo M., Breyer R.M., Peebles R.S., Blackwell T.S., Christman J.W. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur. J. Immunol. 2007, 37:1001-1009.
23. Park G.Y., Hu N., Wang X., Sadikot R.T., Yull Y., Peebles R.S., Blackwell T.S. Christman JW, Conditional regulation of Cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity. Clin. Exp. Immunol. 2007, 150:245-254.
24. 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 2004, 173:559-565.
25. 2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 2007, 37:562-570.
26. 2 as a mediator of allergic asthma. Science 2000, 287:2013-2017.
27. Joo M., Kwon M., Sadikot R.T., Kingsley P.J., Marnett L.J., Blackwell T.S., Peebles R.S., Urade Y., Christman J.W. Induction and function of lipocalin prostaglandin D synthase in host immunity. J. Immunol. 2007, 179:2565-2575.
28. Mandal A.K., Zhang Z., Kim S.J., Tsai P.C., Mukherjee A.B. Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation. J. Immunol. 2005, 175:6271-6273.
29. 2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem. 2001, 276:35530-35536.
30. Berry E.B., Keelan J.A., Helliwell R.J., Gilmour R.S., Mitchell M.D. Nanomolar and micromolar effects of 15-deoxy-delta 12, 14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Mol. Pharmacol. 2005, 68:169-178.
31. Yoon H.J., Jeon S.B., Kim I.H., Park E.J. Regulation of TLR2 expression by prostaglandins in brain glia. J. Immunol. 2008, 180:8400-8409.
32. Szanto A., Nagy L. The many faces of PPARgamma: anti-inflammatory by any means?. Immunobiology 2008, 213:789-803.
33. Kim E.H., Surh Y.J. The role of 15-deoxy-delta(12, 14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. Biochem. Pharmacol. 2008, 76:1544-1553.
34. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12, 14)-prostaglandin j(2). Mol. Cell. Biol. 2004, 24:36-45.
35. Thimmulappa R.K., Scollick C., Traore K., Yates M., Trush M.A., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W., Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem. Biophys. Res. Commun. 2006, 351:883-889.
36. 2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J. 2008, 411:297-306.
37. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006, 116:984-995.
38. 2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 2005, 171:1260-1266.
39. 2. Proc. Natl. Acad. Sci. USA 2007, 104:20979-20984.
40. 2. J. Immunol. 2007, 178:1144-1150.